Pfizer Inc (MIL:1PFE)
€ 24.625 -0.16 (-0.65%) Market Cap: 138.78 Bil Enterprise Value: 192.52 Bil PE Ratio: 34.89 PB Ratio: 1.59 GF Score: 64/100

Pfizer Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2021 / 02:15PM GMT
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Thank you for joining us for the next session. I'm Matthew Harrison, one of the biopharma analysts here at Morgan Stanley. I'm very pleased to have Pfizer with us.

Before we get started, I need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at morganstanley.com/research disclosures.

And with us from Pfizer, we have Frank D'Amelio, who's the CFO; and Chris Stevo, who runs IR. I'm going to turn it over to Chris and Frank to get us started.

Christopher J. Stevo
Pfizer Inc. - Senior VP & Chief IR Officer

Thank you, Matthew. So favorite forward-looking statement from us as well. Before we begin, just a quick reminder on forward-looking statements. We'll be making some forward-looking commentary and statements here. And as you're all familiar, actual results could be different from those. Additional information regarding

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot